Stago Group News

Communication of March 4, 2026

Dear valued Partner,
We are pleased to share an important update regarding Stago's future.

Stago has entered into an exclusive negotiations with ARCHIMED, a healthcare-focused investment firm and La Caisse, also active in the healthcare sector, to support the next phase of our growth.

This step reflects a strategic decision to further strengthen Stago's long-term growth while preserving what has always defined us: scientific excellence, reliability, deep expertise in hemostasis, and a strong commitment to customer partnerships.

Stago webinar: Emerging biomarker for thrombotic risk stratification in coronary artery disease

Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the role of TF-positive platelets in arterial thrombosis and CAD progression, as well as their potential to improve thrombotic risk stratification beyond traditional models.

Stago enters into exclusive negotiations with ARCHIMED and La Caisse

PRESS RELEASE: December 11, 2025

The Stago Group, a global leader in diagnostics and a specialist in hemostasis, announced today that it has entered into exclusive negotiations with a consortium led by ARCHIMED, an investment fund dedicated to the healthcare sector, with a view to acquiring a majority stake in the group. La Caisse (formerly Caisse de dépôt et Placement du Québec) would invest alongside ARCHIMED as a minority investor.

Stago's 2025 CSR Report is online

The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.

New Focus on Extracellular Vesicles

This Focus leaflet illustrates how extracellular vesicles (EVs), once confined to basic research, are now on the path to becoming valuable tools in clinical diagnostics. This last issue has been coordinated by Professor Françoise Dignat-George, recipient of the ISTH Esteemed Career Award 2025.